Autolus Therapeutics PLC reports results for the quarter ended in September - Earnings Summary

Autolus Therapeutics

02/11/2023 22:45

* Autolus Therapeutics PLC  AUTL.OQ  reported a quarterly
adjusted
loss of 26 cents​​ per share for the quarter ended in September,
higher than the same quarter last year, when the company
reported EPS of -47 cents.  The mean expectation of six analysts
for the quarter was for a loss of 25 cents per share. Wall
Street expected results to range from -28 cents to -21 cents per
share.
    * Revenue fell 82.9% to $406.00 thousand from a year ago;
analysts
expected $446.29 thousand. 
    * Autolus Therapeutics PLC's reported EPS for the quarter
was a
loss of 26 cents​.
    * The company reported a quarterly loss of $45.85 million.
    * Autolus Therapeutics PLC shares had risen by 26.6% this
quarter and gained 55.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Autolus
Therapeutics PLC is $9.00 
This summary was machine generated from LSEG data November 2 at
10:45 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -0.25          -0.26          Missed
 Jun. 30 2023      -0.22          -0.26          Missed
 Mar. 31 2023      -0.27          -0.23          Beat
 Dec. 31 2022      -0.27          -0.23          Beat